Harrington, Robert A.
Stanford Medicine · Stanford University
22 papers on CoChatORCID 0000-0001-5450-8676
Most cited papers
- Verified
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine
Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research
Cited by 7,117
- Verified
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., et al. (2018) · New England Journal of Medicine
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 3,634
- Verified
Video-based AI for beat-to-beat assessment of cardiac function
Ouyang, D., He, B., Ghorbani, A., Yuan, N., Ebinger, J., Langlotz, C. P., Heidenreich, P. A., Harrington, R. A., Liang, D. H., Ashley, E. A., et al. (2020) · Nature
Cardiovascular Function and Risk FactorsArtificial Intelligence in Healthcare and Education
Cited by 1,153
- Verified
Ethical and Scientific Implications of the Globalization of Clinical Research
Glickman, S. W., McHutchison, J. G., Peterson, E. D., Cairns, C. B., Harrington, R. A., Califf, R. M., & Schulman, K. A. (2009) · New England Journal of Medicine
Ethics in Clinical ResearchBiomedical Ethics and Regulation
Cited by 710
- Verified
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Bittner, V. A., Szarek, M., Aylward, P. E., Bhatt, D. L., Diaz, R., Edelberg, J. M., Fras, Z., Goodman, S. G., Halvorsen, S., Hanotin, C., et al. (2020) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 572
- Verified
Deep learning interpretation of echocardiograms
Ghorbani, A., Ouyang, D., Abid, A., He, B., Chen, J. H., Harrington, R. A., Liang, D. H., Ashley, E. A., & Zou, J. Y. (2020) · npj Digital Medicine
Artificial Intelligence in HealthcareArtificial Intelligence in Healthcare and Education
Cited by 518
- Verified
Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes
Giugliano, R. P., White, J. A., Bode, C., Armstrong, P. W., Montalescot, G., Lewis, B. S., van `t Hof, A., Berdan, L. G., Lee, K. L., Strony, J. T., et al. (2009) · New England Journal of Medicine
Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research
Cited by 506
- Verified · note
What This Computer Needs Is a Physician: Humanism and Artificial Intelligence
Verghese, A., Shah, N. H., & Harrington, R. A. (2018) · JAMA
Artificial Intelligence in Healthcare and EducationArtificial Intelligence Applications
Cited by 468
- Verified
Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Mahaffey, K. W., Wojdyla, D. M., Carroll, K., Becker, R. C., Storey, R. F., Angiolillo, D. J., Held, C., Cannon, C. P., James, S., Pieper, K. S., et al. (2011) · Circulation
Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research
Cited by 434
- Verified
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
Schwartz, G. G., Bessac, L., Berdan, L. G., Bhatt, D. L., Bittner, V., Diaz, R., Goodman, S. G., Hanotin, C., Harrington, R. A., Jukema, J. W., et al. (2014) · American Heart Journal
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 408
- Verified
Ticagrelor in patients with stable coronary disease and diabetes
Steg, P. G., Bhatt, D. L., Simon, T., Fox, K., Mehta, S. R., Harrington, R. A., Held, C., Andersson, M., Himmelmann, A., Ridderstråle, W., et al. (2019) · New England Journal of Medicine
Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research
Cited by 365
- Verified
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
Jones, W. S., Mulder, H., Wruck, L. M., Pencina, M. J., Kripalani, S., Muñoz, D., Crenshaw, D. L., Effron, M. B., Re, R. N., Gupta, K., et al. (2021) · New England Journal of Medicine
Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research
Cited by 307
- Verified
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome
Jukema, J. W., Szarek, M., Zijlstra, L. E., de Silva, H. A., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., et al. (2019) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 243
- Verified
Feasibility of Obtaining Measures of Lifestyle From a Smartphone App: The MyHeart Counts Cardiovascular Health Study
McConnell, M. V., Shcherbina, A., Pavlovic, A., Homburger, J. R., Goldfeder, R. L., Waggot, D., Cho, M. K., Rosenberger, M. E., Haskell, W. L., Myers, J., et al. (2017) · JAMA Cardiology
Mobile Health and mHealth ApplicationsPhysical Activity and Health
Cited by 239
- Verified · note
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events
Szarek, M., White, H. D., Schwartz, G. G., Alings, M., Bhatt, D. L., Bittner, V. A., Chiang, C.-E., Diaz, R., Edelberg, J. M., Goodman, S. G., et al. (2019) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 173
- Verified
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Schwartz, G. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., Jukema, J. W., Landmesser, U., López-Jaramillo, P., Manvelian, G., Pordy, R., et al. (2021) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 150
- Verified
Machine learning and atherosclerotic cardiovascular disease risk prediction in a multi-ethnic population
Ward, A., Sarraju, A., Chung, S., Li, J., Harrington, R., Heidenreich, P., Palaniappan, L., Scheinker, D., & Rodriguez, F. (2020) · npj Digital Medicine
Machine Learning in HealthcareArtificial Intelligence in Healthcare
Cited by 112
- Verified
Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome
Giraldez, R. R., Clare, R. M., Lopes, R. D., Dalby, A. J., Prabhakaran, D., Brogan, G. X., Giugliano, R. P., James, S. K., Tanguay, J.-F., Pollack, C. V., et al. (2013) · American Heart Journal
Diabetes, Cardiovascular Risks, and LipoproteinsAcute Myocardial Infarction Research
Cited by 111
- Verified
The effect of digital physical activity interventions on daily step count: A randomised controlled crossover substudy of the MyHeart Counts Cardiovascular Health Study
Shcherbina, A., Hershman, S. G., Lazzeroni, L., King, A. C., O'Sullivan, J. W., Hekler, E., Moayedi, Y., Pavlovic, A., Waggott, D., Sharma, A., et al. (2019) · The Lancet Digital Health
Mobile Health and mHealth ApplicationsPhysical Activity and Health
Cited by 90
- Verified
Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial
Goodman, S. G., Steg, P. G., Poulouin, Y., Bhatt, D. L., Bittner, V. A., Diaz, R., Garon, G., Harrington, R. A., Jukema, J. W., Manvelian, G., et al. (2023) · Journal of the American Heart Association
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 44
- Verified
Using Aggregate Patient Data at the Bedside via an On-Demand Consultation Service
Callahan, A., Gombar, S., Cahan, E. M., Jung, K., Steinberg, E., Polony, V., Morse, K., Tibshirani, R., Hastie, T., Harrington, R., et al. (2021) · NEJM Catalyst
Electronic Health Records SystemsMachine Learning in Healthcare
Cited by 24
- Verified
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial
Vaduganathan, M., Harrington, R. A., Stone, G. W., Steg, P. G., Gibson, C. M., Hamm, C. W., Price, M. J., Prats, J., Deliargyris, E. N., Mahaffey, K. W., et al. (2016) · Circulation: Cardiovascular Interventions
Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free